Characterization of FMR1 promoter elements by in vivo-footprinting analysis. - Wikidata - wikimedia - TriplyDB

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

http://www.wikidata.org/entity/Q35250383

about

Fragile X (CGG)n repeats induce a transcriptional repression in cis upon a linked promoter: evidence for a chromatin mediated effect The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors.Interaction of the transcription factors USF1, USF2, and alpha -Pal/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production Biology of the fragile X mental retardation protein, an RNA-binding protein.Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells.FMR1 gene and fragile X syndrome.Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.Fragile X mental retardation protein in plasticity and disease.Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?A distinct DNA-methylation boundary in the 5'- upstream sequence of the FMR1 promoter binds nuclear proteins and is lost in fragile X syndrome.Human pluripotent stem cell models of Fragile X syndrome.Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat.Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation.Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients.

P2860

Q24793185-D9752812-3340-41AF-A15A-8FB43A429AA2 Q25255073-86BC04B3-7F46-45C4-BA2B-1DA6D5499F98 Q28142664-9C2CB9B8-6E65-4993-8FAA-AD7754728FE4 Q28577262-9EF88D79-4D0B-4D91-907F-22F5D8E32B05 Q33765369-6835271D-390B-4677-B2CA-69FA3F06FD15 Q34044576-D6F2AAC7-E61D-469E-A88A-8C5191D83C50 Q34141674-B40D4053-9F8A-4045-BB71-6FC9D679760E Q34145956-BF996A0B-C464-43D8-A29A-2AB17F5FEDEB Q34993137-1D426BB5-C071-4D8C-A5DB-4924D0DE37B0 Q35230078-0234B3C6-8E13-494C-AAB6-01ACD4D44580 Q35433625-5D56F5B2-BD6A-4E25-91FD-8A741A6D81A9 Q37417853-EC027534-D641-49C5-BE27-FBD0C6A418C3 Q38660520-D21AC063-E572-4592-A776-CB53210C68DA Q39681923-61F7917E-845C-4229-AC06-389F1DDB864E Q40505209-62B9273E-6A56-4C48-9455-07E97BC47A46 Q41968306-459001EA-4CF4-44C2-AD44-0339116E1987 Q42481666-1B472CE2-D75E-4D0E-8DD2-EE3D4998E708 Q51983429-B8F608DC-0C8B-4CDC-B93D-A47BF643EEB5

P2860

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

http://www.wikidata.org/entity/Q35250383

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

@ast

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

@en

type

label

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

@ast

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

@en

prefLabel

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

@ast

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

@en

P1433

Q35250383-EC7D6CB5-03D5-461D-A24B-BA98D087F843

P1476

Q35250383-F55C1229-4FD7-4640-8B6A-02CB5CD23234

P2093

Q35250383-05140C25-9767-49FE-8078-42C4EF9B847C

Q35250383-4FDC8902-B66D-4D9E-B8CF-1B83C39F639A

Q35250383-65D88B1B-9882-4475-9C3D-3CDFF250444F

Q35250383-978AB2D6-2EB2-4320-A9DA-83FE3D0445B1

Q35250383-C67B2690-2F2A-46BC-8AD5-97F2A242A756

Q35250383-CAC1993D-E23A-4CE2-A724-E33A7311E6FF

Q35250383-CAF9182B-03B4-4854-A018-DA27B84F39F8

Q35250383-CB0C8E86-0E0E-4DCA-9261-052202144AFA

Q35250383-D735EE92-B1F8-454F-9866-672564D85375

Q35250383-F2D11560-C019-41D6-8869-CBDACC415BC3

P2860

Q35250383-0BF86E95-96C4-4F0F-AFA5-B3B2B94B3BE8

Q35250383-2453C3B8-860A-4EBB-89AE-54016AA767A2

Q35250383-25E1B1FB-571F-4423-BC3D-EB5D23A65B32

Q35250383-43B73231-2993-4135-9A31-D3E1D2DB2AA2

Q35250383-46799536-151E-48B9-B46F-3081DC8E49A4

Q35250383-47DFA957-2C3E-4979-B8EF-1BCC143E3276

Q35250383-4C054421-7A82-4809-A7AD-FC02493E542C

Q35250383-50F8BD34-4128-4E98-BB33-4EF1D949059A

Q35250383-546FBBA6-E240-4EA8-BBEA-9514FE5716D1

Q35250383-5561DA96-CC5B-4B9A-BCED-33D8E19A8331

P304

Q35250383-8DDD21D9-57E5-426D-9F7F-8E069BE5ABE4

P31

Q35250383-92591EFC-38EE-4875-8C2B-897DBA5CEA9A

P356

Q35250383-1D64706E-477F-4708-A9C1-4A2F44BD7F31

P407

Q35250383-018B4C36-4695-4920-BD84-12C8A3B7B91C

P433

Q35250383-7E4AC52C-F596-4E59-A0CC-E24ED435C4E8

P478

Q35250383-4D63ACDA-7F54-4AA6-BEA9-08E60233C5E8

P50

Q35250383-0DF91046-5945-4A7D-845D-02824D0D04E9

P577

Q35250383-114A34B7-4E44-4B5C-9187-B35673B5EF4F

P5875

Q35250383-68475B61-D5B5-44C3-BF4E-ABC3E7ABF3D9

P698

Q35250383-60123E8D-3F59-41AA-AEEA-C9DD5D453615

P932

Q35250383-E9C46D48-1D11-4013-8E98-573C20585460

P356

P1433

American Journal of Human Genetics

P1476

Characterization of FMR1 promoter elements by in vivo-footprinting analysis

@en

P2093

B A Oostra

http://www.w3.org/2001/XMLSchema#string

D Gläser

http://www.w3.org/2001/XMLSchema#string

D Wöhrle

http://www.w3.org/2001/XMLSchema#string

E de Graaff

http://www.w3.org/2001/XMLSchema#string

I Kennerknecht

http://www.w3.org/2001/XMLSchema#string

P Steinbach

http://www.w3.org/2001/XMLSchema#string

S Schwemmle

http://www.w3.org/2001/XMLSchema#string

W Döerfler

http://www.w3.org/2001/XMLSchema#string

W Just

http://www.w3.org/2001/XMLSchema#string

W Vogel

http://www.w3.org/2001/XMLSchema#string

P2860

Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc

Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox

Characterization and localization of the FMR-1 gene product associated with fragile X syndrome

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

Cytosine methylation does not affect binding of transcription factor Sp1

High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome.

Genomic sequencing and methylation analysis by ligation mediated PCR.

Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor.

P304

1354-1362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/515456

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Heidrun L Deissler

P577

1997-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14018906

http://www.w3.org/2001/XMLSchema#string

P698

9199556

http://www.w3.org/2001/XMLSchema#string

P932

1716109

http://www.w3.org/2001/XMLSchema#string